Novomer

Photo

Danimer Buys Novomer for $152 million

US bioplastics company Danimer Scientific has agreed to pay $152 million cash for Novomer, a developer and producer of biodegradable materials. Both companies’ boards of directors have approved the deal, which is expected to close in the third quarter.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.